January 15, 2021
Studstill Media Photo
MENDOTA – The Mississippi Valley Regional Blood Center will be coming to a Mendota area church on Tuesday. Individuals who want to make a donation will need to register to schedule a time during the event at the First Presbyterian Church of Mendota. The Donor Bus will be in the parking lot from 3 PM – 6 PM, and donation times are limited. Visit Bloodcenter.org to register.
Local Weather
Convalescent Plasma Reduced COVID-19 Deaths, Study Says medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Jan 15, 2021
Death benefit not seen in patients on mechanical ventilation
Among patients hospitalized with Covid-19 not receiving mechanical ventilation, treatment with high-titer convalescent plasma was associated with a lower risk for death than those receiving plasma with low antibody, according to peer-reviewed findings from a retrospective analysis of more than 3,000 patients.
In addition, patients who received convalescent plasma very early – within 3 days of receiving a diagnosis of Covid-19 – had a lower risk of death than those who received the treatment later in the disease course.
Findings from the study of patients enrolled in the Mayo Clinic’s Covid-19 Convalescent Plasma Extended-Access Program were published ahead of peer review in mid-August, and they were instrumental in the decision by the U.S. Food and Drug Administration to grant emergency-use authorization (EUA) status for convalescent plasma for the treatment of adults hospitalized with Covid-19.
Convalescent plasma therapy is when the liquid portion of blood is taken from a recovered coronavirus patient
It is transferred into a sick patient in hopes they will develop the antibodies needed to fight off the infection
Researchers looked at 3,082 hospitalized COVID-19 patients who received blood plasma transfusions
Just 22.3% of patients who received antibody-rich plasma died compared to 29.6% of those given plasma with low level of antibodies
Outcomes were better for those who were given the treatment within three days and were not on mechanical ventilation